Comorbid CVD May Up Mortality With ADT for Prostate Cancer
TUESDAY, Aug. 13, 2019 -- Elderly prostate cancer patients with preexisting cardiovascular diseases (CVDs) using abiraterone acetate (AA) or enzalutamide (ENZ) have higher short-term mortality compared with their counterparts without CVDs, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Pharmaceuticals | Prostate Cancer